BMED was established in 2017 and has taken its place in the Turkish pharmaceutical
sector with the supply of medicines used in the treatment of rare diseases. BMED,
which cooperates with the world's leading companies, aims to ensure that its products and
services are delivered to patients in the easiest, reliable and fastest manner within the
framework of ethical and scientific values.Ophthalmology, Endocrinology, Urology, especially
Oncology, Hematology and Neurology branches, used in the treatment of rare diseases in
the market has taken place.
Headquartered in Ankara, BMED has offices in Istanbul
and Izmir. BMED is responsible for medicines used in the treatment of rare diseases
in Turkey and carries out the sales and marketing with BMED own staff. BMED has distribution partners from 7 different countries, and 8 partners of their
medicines to ensure the attainment of the patients who need treatment in Turkey. BMED is constantly enriching its portfolio of medicines in the treatment of rare diseases
in Turkey and continues its path towards the goal of becoming the largest pharmaceutical
company in this area.